RVTY vs TMO vs TECH Stock Comparison

Revvity, Thermo Fisher Scientific and Bio-Techne Prices as of Nov 13, 2026 Peers: Industry group
1 more company in this comparison (ILMN) Create a free account to keep reading and compare up to 10 companies.
RVTY Revvity, Inc.
$154.52 +1.5% 1M +65.4% 1Y
Market cap
$16.74B
P/E
66.1x
Revenue (TTM)
$2.94B
Div. yield
0.00%
Life Sciences Tools Healthcare
1 win
TECH BIO-TECHNE Corp
$72.80 +0.4% 1M +19.8% 1Y
Market cap
$11.41B
P/E
66.4x
Revenue (TTM)
$1.23B
Div. yield
0.00%
Life Sciences Tools Healthcare
3 wins

Head to Head

12 decided of 12

Thermo Fisher Scientific leads on 8 of the 12 questions below (Thermo Fisher Scientific 8, Bio-Techne 3, Revvity 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionRVTYTMOTECHLeader
Larger companyMarket capitalisation $16.74B $256.30B $11.41B TMO
Cheaper on earningsLower P/E, profitable companies only 66.1x 36.2x 66.4x TMO
Cheaper on forward earningsLower price / next fiscal year consensus EPS 29.9x 27.0x 33.4x TMO
Faster revenue growthRevenue growth, trailing twelve months +4.6% +8.3% +0.9% TMO
More profitableNet margin, trailing twelve months 8.6% 14.9% 14.0% TMO
Better return on capitalReturn on invested capital 3.3% 8.0% 7.8% TMO
Less leveragedLower net debt / EBITDA 2.6x 3.1x -0.4x TECH
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% TECH
Better 1-year returnPrice return, last 12 months +65.4% +20.7% +19.8% RVTY
Better 5-year returnAnnualised price return, 5 years -3.4%/yr +2.0%/yr -10.4%/yr TMO
Less volatileAnnualised volatility, 1 year 41.2% 30.7% 42.8% TMO
Higher overall scoreMean of the five percentile scores vs peers 61/100 60/100 68/100 TECH

Percentile Scorecard

RVTYTMOTECH

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisRVTYTMOTECH
Valuation 72 #70 of 243 62 #94 of 243 62 #92 of 243
Growth 38 #141 of 228 41 #136 of 228 56 #102 of 228
Profitability 81 #43 of 222 82 #40 of 222 94 #15 of 222
Financial Health 56 #110 of 248 31 #172 of 248 79 #53 of 248
Shareholder Returns 56 #70 of 158 82 #29 of 158 47 #84 of 158
Overall 61 60 68
  • RVTY ranked among 252 companies in Medical Devices and Diagnostics
  • TMO ranked among 252 companies in Medical Devices and Diagnostics
  • TECH ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodRVTYTMOTECHSPY
1 month +1.5%+4.0%+0.4% -2.0%
3 months +32.2%+19.1%+0.6% -2.8%
6 months +64.4%+59.7%+68.1% +2.0%
Year to date +59.7%+20.8%+23.8% +10.6%
1 year +65.4%+20.7%+19.8% +12.2%
3 years +75.9%+52.5%+20.6% +68.1%
3 years, per year +20.7%+15.1%+6.5% +18.9%
5 years -15.8%+10.2%-42.3% +61.4%
5 years, per year -3.4%+2.0%-10.4% +10.1%
10 years +203.6%+362.9%+173.4% +248.5%
10 years, per year +11.7%+16.6%+10.6% +13.3%

Risk

MeasureRVTYTMOTECHSPY
Volatility, 1Y 41.2%30.7%42.8% 13.6%
Downside volatility, 1Y 37.1%29.2%43.2% 13.9%
Beta vs S&P 500, 1Y 1.220.710.63 1.00
Return / volatility, 1Y 1.590.670.46 0.90
Max drawdown, 5Y -59.2%-41.5%-66.5% -25.4%
From 52-week high -6.8%-3.0%-0.1% -3.2%
52-week high $165.78$721.63$72.84 $779.14
52-week low $82.26$438.34$43.30 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleRVTYTMOTECH
P/E now vs peer median 68.1xmedian 26.5x 36.6xmedian 26.5x 66.4xmedian 26.5x
P/S now vs peer median 5.9xmedian 2.7x 5.5xmedian 2.7x 9.3xmedian 2.7x
EV/EBITDA now vs peer median 24.4xmedian 18.4x 25.5xmedian 18.4x 33.4xmedian 18.4x
P/FCF now vs peer median 28.7xmedian 25.4x 34.2xmedian 25.4x 37.1xmedian 25.4x
P/B now vs peer median 2.4xmedian 2.5x 4.7xmedian 2.5x 5.3xmedian 2.5x
PEG now vs peer median -2.46median 0.98 4.84median 0.98 -6.27median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsRVTYTMOTECH
Revenue $2.94B $47.35B $1.23B
Gross profit $1.64B $19.45B $807.58M
Operating income $372.09M $8.47B $240.84M
Net income $253.20M $7.09B $171.97M
Free cash flow $601.13M $7.60B $308.20M
R&D $213.15M $1.40B $96.87M
EPS (diluted) $2.26 $19.06 $1.09
Cash & equivalents $592.80M $5.46B $350.04M
Total debt $2.63B $41.37B $200.00M
Shares (diluted) 111.83M 371.00M 157.93M
Enterprise value $13.34B $232.82B $10.42B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricRVTYTMOTECH
P/E 68.1x 36.6x 66.4x
P/FCF 28.7x 34.2x 37.1x
P/Operating cash flow 25.9x 27.8x 33.9x
P/S 5.9x 5.5x 9.3x
P/B 2.4x 4.7x 5.3x
P/Tangible book 3.4x 7.1x 6.1x
EV/EBITDA 24.4x 25.5x 33.4x
EV/EBIT 51.8x 34.8x 46.9x
EV/Revenue 6.6x 6.2x 9.2x
EV/FCF 32.1x 38.8x 36.6x
EV/Operating cash flow 28.9x 31.6x 33.4x
PEG (3Y EPS CAGR) -2.46 4.84 -6.27

Growth

14 metrics
MetricRVTYTMOTECH
Revenue growth (1Y) 4.6% 8.3% 0.9%
Revenue CAGR (3Y) 1.7% 2.9% 2.4%
Gross profit growth (1Y) 5.8% 7.8% 1.5%
Gross profit CAGR (3Y) 1.2% 4.0% 1.4%
Operating income growth (1Y) 2.3% 12.8% 119.1%
Operating income CAGR (3Y) 1.0% 7.2% -6.9%
Net income growth (1Y) 6.6% 7.9% 120.5%
Net income CAGR (3Y) -30.1% 6.2% -11.3%
EPS growth (1Y) 10.1% 9.7% 118.3%
EPS CAGR (3Y) -27.6% 7.6% -10.6%
Operating cash flow growth (1Y) 14.4% 21.9% 34.4%
Operating cash flow CAGR (3Y) 49.3% 4.5% 9.4%
Free cash flow growth (1Y) 19.1% 24.3% 37.6%
Free cash flow CAGR (3Y) 44.7% 5.1% 12.7%

Profitability

14 metrics
MetricRVTYTMOTECH
Gross margin 55.9% 41.1% 65.8%
EBITDA margin 26.8% 24.4% 27.5%
Operating margin 12.6% 17.9% 19.6%
Pretax margin 9.6% 16.7% 18.5%
Net margin 8.6% 14.9% 14.0%
FCF margin 20.4% 16.0% 25.1%
Operating cash flow margin 22.7% 19.7% 27.5%
Return on equity 3.5% 13.2% 7.7%
Return on assets 2.2% 6.2% 6.3%
Return on invested capital 3.3% 8.0% 7.8%
Return on capital employed 3.4% 8.5% 10.7%
Asset turnover 0.2x 0.4x 0.5x
Cash conversion (OCF / net income) 2.6x 1.3x 2.0x
Stock comp / revenue 0.9% 0.7% 1.6%

Financial Health

11 metrics
MetricRVTYTMOTECH
Debt / assets 22.9% 36.2% 7.6%
Debt / equity 0.4x 0.8x 0.1x
Net debt / EBITDA 2.6x 3.1x -0.4x
Debt / FCF 4.4x 5.4x 0.6x
Liabilities / assets 36.7% 52.1% 17.9%
Equity / assets 63.3% 47.9% 82.1%
Interest coverage 4.2x 12.0x 27.2x
Current ratio 2.7x 1.8x 2.3x
Quick ratio 1.9x 1.2x 1.5x
Cash ratio 0.8x 0.4x 1.0x
Altman Z-score 3.69 4.18 16.15

Shareholder Returns

7 metrics
MetricRVTYTMOTECH
Dividend yield 0.2% 0.3% 0.5%
Net buyback yield 1.5% 1.6% -0.5%
Shareholder yield 1.7% 1.8% 0.1%
Payout ratio (earnings) 12.4% 9.5% 29.1%
Payout ratio (FCF) 5.2% 8.9% 16.2%
Dividend growth (1Y) -5.9% 8.0% -0.2%
Dividend CAGR (3Y) -6.2% 10.1% -0.2%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusRVTYTMOTECH
Forward P/E 29.9xFY2026 27.0xFY2026 33.4xFY2027
EPS, next fiscal year $5.16FY2026 $25.92FY2026 $2.18FY2027
EPS growth, next FY +2.0%FY2026 +13.3%FY2026 +13.0%FY2027
EPS growth, the year after +11.0% +2.2% +3.2%
Revenue, next fiscal year $3.00BFY2026 $50.12BFY2026 $1.19BFY2027
Revenue growth, next FY +4.8%FY2026 +12.5%FY2026 -2.1%FY2027
Revenue growth, the year after -2.0% -2.7% +13.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersRVTYTMOTECH
Held by institutions 100.0% 90.2% 100.0%
Institutions holding 547 2,627 599
Change in shares held, QoQ -1.3% +0.8% -0.6%
Institutions buying 303 1,145 293
Institutions selling 161 1,145 241
Buyers to sellers 1.88 1.00 1.22

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

RVTYTMOTECH
RVTY 1.00 0.72 0.42
TMO 0.72 1.00 0.45
TECH 0.42 0.45 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, RVTY, TMO and TECH?

Thermo Fisher Scientific (TMO) is the largest by market capitalisation: Revvity (RVTY) $16.74B, Thermo Fisher Scientific (TMO) $256.30B, Bio-Techne (TECH) $11.41B.

Which stock is cheaper, RVTY, TMO and TECH?

Thermo Fisher Scientific (TMO) trades on the lowest price-to-earnings ratio (Revvity (RVTY) 66.1x, Thermo Fisher Scientific (TMO) 36.2x, Bio-Techne (TECH) 66.4x). On next year's consensus earnings, Thermo Fisher Scientific (TMO) is cheapest (Revvity (RVTY) 29.9x, Thermo Fisher Scientific (TMO) 27.0x, Bio-Techne (TECH) 33.4x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Thermo Fisher Scientific (TMO) grew revenue fastest over the trailing twelve months: Revvity (RVTY) +4.6%, Thermo Fisher Scientific (TMO) +8.3%, Bio-Techne (TECH) +0.9%.

Which company is more profitable?

Thermo Fisher Scientific (TMO) has the highest net margin (Revvity (RVTY) 8.6%, Thermo Fisher Scientific (TMO) 14.9%, Bio-Techne (TECH) 14.0%). On return on invested capital, Thermo Fisher Scientific (TMO) leads (Revvity (RVTY) 3.3%, Thermo Fisher Scientific (TMO) 8.0%, Bio-Techne (TECH) 7.8%).

Which stock has performed better?

Over the past year Revvity (RVTY) returned the most: Revvity (RVTY) +65.4%, Thermo Fisher Scientific (TMO) +20.7%, Bio-Techne (TECH) +19.8%. Over five years, Thermo Fisher Scientific (TMO) compounded fastest (Revvity (RVTY) -3.4%/yr, Thermo Fisher Scientific (TMO) +2.0%/yr, Bio-Techne (TECH) -10.4%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Bio-Techne (TECH) has the highest dividend yield: Revvity (RVTY) 0.00%, Thermo Fisher Scientific (TMO) 0.00%, Bio-Techne (TECH) 0.00%.

Which stock is riskier?

By one-year price volatility, Thermo Fisher Scientific (TMO) has been the steadiest (Revvity (RVTY) 41.2%, Thermo Fisher Scientific (TMO) 30.7%, Bio-Techne (TECH) 42.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, RVTY, TMO and TECH?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Thermo Fisher Scientific (TMO) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.